NCT06919744View on ClinicalTrials.gov

Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase

NARecruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

September 19, 2025

Primary Completion Date

October 30, 2028

Study Completion Date

April 30, 2029

Conditions
Idiopathic Intracranial Hypertension (IIH)
Interventions
DRUG

Best medical care

Acetazolamide will be introduced at the time of papilledema discovery. Weight loss will be recommended.

DEVICE

Intervention (stenting)

Transverse venous sinus will be stented by neuro-radiological intervention

Trial Locations (3)

31000

NOT_YET_RECRUITING

CHU de Toulouse, Toulouse

34295

RECRUITING

CHU de Montpellier Hôpital Gui de Chauliac, Montpellier

51092

NOT_YET_RECRUITING

CHU de REIMS, Reims

All Listed Sponsors
collaborator

Ministère de la Santé

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT06919744 - Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase | Biotech Hunter | Biotech Hunter